Accelerator Corp.
Company launched to develop protein-based therapeutics
Published in Medicine and Law Weekly, December 9th, 2005
The Series A investment in Allozyne was led by a syndicate of investors: Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, MPM Capital and OVP Venture Partners.
Allozyne was founded to commercialize proprietary technologies developed in the laboratories of David Tirrell and William Goddard at Caltech. These technologies will enable the company to improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics. This is achieved...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Aarhus University Hospital
Ethical and practical problems exist in blood sampling for research during emergencies - AstraZeneca Pharmaceuticals, L.P.
Pulmicort Respules well-tolerated in children with severe asthma - Boston Scientific Corp.
New Medicare reimbursement codes approved for rechargeable neurostimulators - Competitive Technologies, Inc.
U.S. Supreme Court agrees to hear appeal on homocysteine patentability issue - Cord Blood Registry
Newborn stem cell bank announces settlement of litigation with Viacord - Cyberonics, Inc.
Medicare outpatient reimbursement rates for 2006 for VNS therapy posted - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
